Nutriband Inc.将其反滥用毒品补丁技术专利扩大到澳门,计划在2025年获得林业发展局的批准。 Nutriband Inc. extends patent for its anti-abuse drug patch technology to Macao, plans FDA approval in 2025.

Nutriband Inc.是一家开发防滥用转基因药物补丁的公司,已将其专利扩展到澳门,增加了46个国家的现有专利。 Nutriband Inc., a company developing anti-abuse transdermal drug patches, has extended its patent to Macao, adding to its existing patents in 46 countries. AVERSATM技术旨在防止类鸦片和兴奋剂等药物滥用。 The AVERSA™ technology aims to prevent abuse of drugs like opioids and stimulants. 2025年,Nutriband计划争取林业发展局批准其AVERSATM Fentanyl补丁,每年销售额可能高达2亿美元。 Nutriband plans to seek FDA approval for its AVERSA™ Fentanyl patch in 2025, with potential annual sales of up to $200 million.